4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. financial statements

4D Molecular Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 85.21M10-K
Net income−USD 140.11M10-K
Cash and equivalentsUSD 60.24M10-Q
Total debtUSD 010-Q

4D Molecular Therapeutics, Inc. financials on 6ix · 4D Molecular Therapeutics, Inc. on 6ix